EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Open Access · CC BY-NC 4.0

Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives

Rebecca Moore, Joshua Poulsen, Lindsay Reardon, Candice Samples-Morris, Holly Simmons, Keri M Ramsey iD, Meagan L Whatley, Jane B Lane

Advances in Therapy · 2024

DOI: 10.1007/s12325-024-02782-4 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Advances in Therapy, 2024. Verfasst von Rebecca Moore und 7 weiteren Autor:innen. Beteiligte Einrichtung: Caregiver Author, Redmond, OR, USA. Hauptthemen laut MEDLINE: Gastrointestinal Diseases, Rett Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ACADIA Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rett syndrome (RTT) is a rare genetic neurodevelopmental disorder mainly affecting female individuals. Trofinetide was recently approved as the first treatment for RTT, largely on the basis of results from the phase 3 LAVENDER trial, in which trofinetide showed improvements in core symptoms of RTT compared with placebo. However, gastrointestinal (GI) symptoms such as diarrhea and vomiting were commonly reported side effects, and taste was also a reported issue. The objective of this article is to describe the perspectives of five caregivers of girls in trofinetide clinical trials as well as those of three nurse trial coordinators, with a focus on management of GI symptoms of trofinetide treatment.Audio Abstract available for this article. Audio Abstract: Jane Lane provides an overview and discusses key findings of the article titled "Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives." (MP4 83274 KB).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal DiseasesRett SyndromeFemaleHumansCaregiversCausalityGlutamates

Stichwörter der Autor:innen

DiarrheaRett syndromeTasteTrofinetideVomiting

Substanzen

Glutamatestrofinetide

Autor:innen und Institutionen

  • Caregiver Author, Redmond, OR, USA.
  • Caregiver Author, Albuquerque, NM, USA.
  • Caregiver Author, Darien, CT, USA.
  • Caregiver Author, Jacksonville, FL, USA.
  • Caregiver Author, West Chester, PA, USA.
  • Center for Rare Childhood Disorders, Translational Genomics Research Institute, Phoenix, AZ, USA.

ORCID-Profile: Keri M Ramsey

Förderung

  • ACADIA Pharmaceuticals

Zitieren

APA

Moore, R., Poulsen, J., Reardon, L., Samples-Morris, C., Simmons, H., Ramsey, K. M., Whatley, M. L., & Lane, J. B. (2024). Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives. Advances in Therapy. https://doi.org/10.1007/s12325-024-02782-4

Vancouver

Moore R, Poulsen J, Reardon L, Samples-Morris C, Simmons H, Ramsey KM, et al. Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives. Advances in Therapy. 2024. doi:10.1007/s12325-024-02782-4

BibTeX
@article{Moore2024,
  author = {Moore, Rebecca and Poulsen, Joshua and Reardon, Lindsay and Samples-Morris, Candice and Simmons, Holly and Ramsey, Keri M and Whatley, Meagan L and Lane, Jane B},
  title = {Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives},
  journal = {Advances in Therapy},
  year = {2024},
  doi = {10.1007/s12325-024-02782-4}
}
Kostenlos starten →